The PCI Fellows had a lovely potluck at Tomas’s house in January. They shared their latest news, brought great food to share, and even had piano performances by Max and Dora.
Penn Scientists New Research Shows That a CAR-T gel Treatment May Be Able to Kill Residual Cancer Cells Left Over from Surgery
In the study, Penn scientists added CAR-T cells to a gel designed to prevent bleeding after surgery and applied it to the surgical wounds of mice after they had hard-to-treat tumors resected.
On January 9th, 2023 PCI was proud to present a star-studded program entitled “The Future of mRNA Technology” at Wharton San Francisco during the JP Morgan Healthcare Conference.
Three Penn Spinouts Made Philadelphia Business Journal’s PHLInno List of Top Philadelphia Startups to Watch in 2023
Exciting news for three innovative Penn spinouts.
Karikó and Weissman were named to the National Inventors Hall of Fame for their mRNA research which made covid-19 vaccines possible.
In Fall 2022, ten teams participated in the Penn I-Corps Program, representing the Schools of Arts and Sciences, Engineering, Medicine, Veterinary Medicine, and Business.
There are a wide range of Penn spinouts across industries that are working on innovative and transformative products and projects. This is a list of Penn startups currently raising money in 2023.
Penn’s Abramson Cancer Center Presents New Cancer Research at 2022 American Society of Hematology (ASH) Annual Meeting
Researchers from Penn’s Abramson Cancer Center presented the preliminary results of an ongoing Phase I clinical trial for a novel CAR T therapy to be used after cancer.
Peter Psarras, a research assistant professor in chemical and biomolecular engineering, and his colleagues are repurposing waste from industrial mines.
Penn spinout Peroxitech raised $25M to further develop its novel drug candidate, PIP-2.